Clinical trials: Chatbot
Major Depressive Disorder
Optimize and Predict Antidepressant Efficacy for Patient With MDD Using Multi-omics Analysis and AI-predictive Tool
OPADE is a non-profit, observational, multicenter, open-label study aimed at defining personalized treatment for Major Depressive Disorder (MDD).
- Trial name
- OPADE (NCT06550037)
- Where
- Italy
- Volunteers
- 350 people
- Sponsor
- Alessio Fasano
Cardiovascular-kidney-metabolic Syndrome
AI Chatbot-Enabled ePRO Monitoring and Nurse-Led Self-Management for Early-Stage Cardiovascular-Kidney-Metabolic Syndrome
This randomized controlled trial will evaluate the effectiveness of an AI chatbot-enabled electronic patient-reported outcome (ePRO) monitoring and nurse-led self-management intervention for adults with early-stage…
- Trial name
- NCT07577284
- Testing
- AI chatbot-enabled nurse-led program., Usual Care
- Where
- Taiwan
- Volunteers
- 80 people
- Sponsor
- Taipei Medical University
Depression - Major Depressive Disorder, Depression Anxiety Disorder
Evaluating the Effectiveness and Acceptability of a GPT-4o and RAG-Based Voice Chatbot for Depression Screening Using PHQ-9
This study aims to assess the feasibility and acceptability of a voice-based chatbot, powered by GPT-4o and Retrieval-Augmented Generation (RAG), for conducting depression screening using the Patient Health Questionnaire-9…
- Trial name
- GPT4-RAG-PHQ (NCT06801925)
- Testing
- GPT-4o and RAG Voice Chatbot for PHQ-9 Screening
- Where
- United Kingdom
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- University College, London
Breast Cancer
Design and Pilot Implementation of a Chatbot to Support Breast Cancer Screening Among Black Women
Black women are more likely than White women to be diagnosed at later stages and to die from breast cancer. Increasing breast cancer screening rates could help improve early detection of and survival from breast cancer.
- Trial name
- NCT07858825
- Testing
- Chatbot
- Volunteers
- 873 people, healthy volunteers welcome
- Sponsor
- University of Washington
Gastrointestinal Cancer
'Penny', a SMS Text-based Chatbot Intervention for Medication Adherence and Side Effect Management Among Patients With GI Cancers
There has been a dramatic paradigm shift over the last 25 years within cancer care due to the onset of many new targeted therapies and a transition from inpatient to outpatient care.
- Trial name
- NCT05113264
- Testing
- 'Penny' via Memora Platform
- Where
- United States
- Volunteers
- 60 people
- Sponsor
- Abramson Cancer Center at Penn Medicine
Telephone Hotlines, AI Chatbot
Comparing the Effectiveness of AI Chatbot with That of Telephone Hotline
The COVID-19 pandemic has significantly impacted the wellbeing of people in Hong Kong, leading to social distancing policies and changes in healthcare service utilization.
- Trial name
- AI chatbot (NCT06621134)
- Testing
- AI Chatbot, Telephone hotline
- Where
- Hong Kong
- Volunteers
- 48 people
- Sponsor
- The University of Hong Kong
Head and Neck Cancer
An Oncology Nurse AI Agent to Reduce Cancer Distress During Radiotherapy
The goal of this clinical trial is to assess the effectiveness of the Digi-Coach chatbot for reducing physical and psychological distress in people undergoing radiotherapy for head and neck cancer.
- Trial name
- Digi-Coach (NCT06636188)
- Testing
- Digi-Coach Chatbot
- Where
- 2 sites in Hong Kong
- Volunteers
- 138 people
- Sponsor
- The University of Hong Kong
Osteo Arthritis Knee and Hip, Artificial Intelligence (AI)
Comparing Physician and Artificial Intelligence Chatbot Responses to Frequently Asked Questions From Osteoarthritis Patients
This study aimed to compare the patient acceptability (preference, length, and difficulty) and accuracy of Chat-Generative Pre-Trained Transformer (ChatGPT) responses to questions from people with osteoarthritis (OA) with…
- Conditions
- Osteo Arthritis Knee and Hip, Artificial Intelligence (AI), Acceptability, Accuracy
- Trial name
- PARTICIPATE (NCT07202286)
- Where
- Netherlands
- Volunteers
- 286 people
- Sponsor
- Canisius-Wilhelmina Hospital
Influenza Vaccines
Vaccine Chatbot for Improving Influenza Vaccination Uptake
This study aims to assess the impact of a vaccine chatbot on improving influenza vaccination uptake among children aged between 6 and 59 months through a cluster randomized trial.
- Trial name
- NCT06657573
- Testing
- An AI-enabled chatbot tailored for influenza vaccine consultation
- Where
- China
- Volunteers
- 1,200 people, healthy volunteers welcome
- Sponsor
- Fudan University
Parkinson Disease, Occupational Therapy Students
Effect of AI Chatbot-Assisted Versus Traditional Case-Based Learning on Clinical Reasoning in Occupational Therapy Students: A Study on Parkinson's Disease
This study aims to examine whether using an artificial intelligence (AI) chatbot can enhance occupational therapy students' learning during a case-based activity focused on Parkinson's disease.
- Conditions
- Parkinson Disease, Occupational Therapy Students, Clinical Reasoning, Neurologic Rehabilitation
- Trial name
- AI-PD-OT25 (NCT07045077)
- Testing
- AI Chatbot-Assisted Case-Based Learning, Traditional Case-Based Learning with Standard Materials
- Where
- Turkey (Türkiye)
- Volunteers
- 25 people, healthy volunteers welcome
- Sponsor
- Ceyhun Türkmen
Exercise Adherence, Healthy Aging
Effectiveness of a Smartphone Chatbot to Improve Exercise Adherence in Older Adults
This randomized controlled trial aims to evaluate the effectiveness of a smartphone-based chatbot in improving adherence to a 12-week home-based multicomponent exercise program in community-dwelling older adults.
- Trial name
- EXEBOT (NCT07832097)
- Testing
- Chatbot-Supported Home-Based Exercise Program, Paper-Based Home Exercise Program Mostrar más líneas
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- University of Valencia
Diabetes, Diabetes Mellitus, Type 2
Diabetes Companion App for Adults With Diabetes and Their Carers
Diabetes self-management support, education, and training are increasingly being delivered through digital technology such as mobile phones.
- Conditions
- Diabetes, Diabetes Mellitus, Type 2, Diabetes Mellitus, Diabetes Type 2
- Trial name
- NCT05535842
- Testing
- GLOW
- Where
- 2 sites in Singapore
- Volunteers
- 224 people
- Sponsor
- Nanyang Technological University
Behavior
A Chatbot to Reduce Chemsex and HIV-related Risk Behaviors Among Men Who Have Sex With Men
The goal of this clinical trial is to investigate whether receiving chatbot-delivered stage-of-change-tailored online interventions is effective in reducing chemsex among men who have sex with men in Hong Kong.
- Trial name
- NCT07472582
- Testing
- Chatbot-delivered online interventions and online videos, Online videos only
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- Chinese University of Hong Kong
Cancer, Financial Toxicity
SAFE.AI: Developing and Testing an AI-based Hybrid Chatbot for Financial Empowerment in Rural Cancer Care
This is a randomized, two-arm, parallel-group pilot trial investigating a new chatbot tool designed to support cancer patients and caregivers, particularly those in rural communities.
- Trial name
- NCT07410689
- Testing
- Rule-Based Chatbot, Hybrid Chatbot
- Where
- United States
- Volunteers
- 60 people
- Sponsor
- University of Utah
Geriatric Cancer Patients
A Chatbot-Powered G8 Screening Intervention to Facilitate Referrals to a Comprehensive Geriatric Assessment Among Older Adults With Cancer
In this prospective quality improvement study, we will develop and evaluate the feasibility and acceptability of an online patient self-reported G8 screening tool which will allow us to efficiently identify G8 positive older…
- Trial name
- NCT05535140
- Testing
- G8 Screening Tool
- Where
- United States
- Volunteers
- 100 people
- Sponsor
- Thomas Jefferson University
Informed Consent
Chatbot Implementation In The Clinical Informed Consent Process
The purpose of this study is to determine the feasibility of implementing the chatbot "CoCo" in the IC process for research studies.
- Trial name
- NCT07756515
- Testing
- CoCo Chatbot
- Where
- United States
- Volunteers
- 100 people
- Sponsor
- M.D. Anderson Cancer Center
Smoking Cessation
Pilot Trial of the First Conversational Agent for Smoking Cessation (QuitBot)
Conversational agents (CAs) are computer-powered digital coaches designed to form long-term social-emotional connections with users through conversations. We have developed a CA for cigarette smoking cessation.
- Trial name
- QuitBot (NCT03585231)
- Testing
- Immediate access to novel messaging program intervention, Immediate access to standard of care messaging program intervention, Delayed access to novel novel messaging program intervention
- Where
- United States
- Volunteers
- 404 people, healthy volunteers welcome
- Sponsor
- Fred Hutchinson Cancer Center
Healthy Lifestyle
A Pilot Randomized Controlled Trial of Chatbot Use in Older Adults for Lifestyle Change
The purpose of this study is to evaluate the acceptability and preliminary effectiveness of a smartphone-delivered AI-based chatbot in promoting healthy dietary behavior and physical activity participation among older adults.
- Trial name
- NCT06901037
- Testing
- A chatbot-based intervention
- Where
- Hong Kong
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- The Hong Kong Polytechnic University
Artificial Intelligence (AI), Electronic Fetal Monitoring
Chatbot About Electronic Fetal Monitoring
The study aims to investigate the effect of using artificial intelligence Chatbot education about electronic fetal monitoring on maternity nursing students' performance. The aim will be achieved through the following, 1.
- Conditions
- Artificial Intelligence (AI), Electronic Fetal Monitoring, Nursing Students
- Trial name
- NCT07051343
- Testing
- designed artificial intelligence Chatbot education about electronic fetal monitoring, traditional teaching method
- Where
- Egypt
- Volunteers
- 84 people, healthy volunteers welcome
- Sponsor
- Mansoura University
Cardiovascular Diseases, Lifestyle Factors
Using AI Text Messaging to Improve AHA's Life's Essential 8 Health Behaviors
The goal of our pragmatic clinical trial is to compare how well three different strategies might do to reduce risk factors for cardiovascular disease in patients experiencing health disparities.
- Trial name
- NCT06324981
- Testing
- Generic text messages, Interactive AI chatbot text messaging, Proactive pharmacist support
- Where
- 3 sites in United States
- Volunteers
- 2,100 people
- Sponsor
- University of Colorado, Denver